A weightlifter describes months of fatigue and twitching after BPC-157, as HHS pushes to ease limits on six peptides FDA scientists flagged for risks.
Recap by typeshit. Full story at Texarkana Gazette.
She walks through the phase 3 data, including knee osteoarthritis results, and explains why she calls online reta vials a gamble.
In a Healio Eye-Mail brief, she gives her view on a review of a possible link between GLP-1 medications and NAION, a type of optic nerve damage.
Retatrutide is still in clinical trials, yet people are discussing using it online. A new analysis takes a first systematic look at the side effects they describe.
The Atlanta Journal-Constitution looks at how an unapproved weight loss drug is being sold through an underground market across Georgia.
A TikTok playlist collects GLP-1 updates from creator @stephaniemua1. There is no detail on what the videos cover beyond the playlist name.
Wayne Pratt walks through what happens in the brain when drugs like Ozempic dial down the constant background chatter about eating.
Loading…